Trial Details
RECRUITINGBasic Information
| Clinical ID | c1443 |
|---|---|
| Identifier | NCT04738942 |
| Trial Title | A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Toyota |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-06-04 |
|---|---|
| Primary Completion Date | 2025-06-30 |
| Completion Date | 2027-11-30 |